Sanofi A/S — Credit Rating and Financial Key Figures

Sanofi A/S (CVR number: 19064301) is a company from KØBENHAVN. The company reported a net sales of 452.6 mDKK in 2024, demonstrating a decline of -14.2 % compared to the previous year. The operating profit percentage was at 2.1 % (EBIT: 9.6 mDKK), while net earnings were 6217 kDKK. The profitability of the company measured by Return on Assets (ROA) was 5.8 %, which can be considered decent but Return on Equity (ROE) was 12.3 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 27.9 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Sanofi A/S's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.